523 results on '"Kamada, Nobuhiko"'
Search Results
2. Metabolic network of the gut microbiota in inflammatory bowel disease
3. The oral-gut axis: a missing piece in the IBD puzzle
4. CD115− monocytic myeloid-derived suppressor cells are precursors of OLFM4high polymorphonuclear myeloid-derived suppressor cells
5. Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases
6. The Microbiome in Quiescent Crohn’s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways
7. DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk.
8. Inflammatory bowel disease and carcinogenesis
9. Pathogenic associations between oral and gastrointestinal diseases
10. The gut–liver axis in HCV infection
11. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel
12. Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa
13. Inflammation induced Th17 cells synergize with the inflammation-trained microbiota to mediate host-resiliency against intestinal injury
14. A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules
15. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota
16. Dietary l-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut
17. Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
18. Intestinal overgrowth of Candida albicans exacerbates bleomycin‐induced pulmonary fibrosis in mice with dysbiosis
19. Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer
20. Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis
21. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
22. The Fecal Microbiome in Quiescent Crohns Disease with Persistent Gastrointestinal Symptoms Show Enrichment of Oral Microbes But Depletion of Butyrate and Indole Producers
23. Tu1868 PROTECTIVE EFFECTS OF NEONATE-SPECIFIC MICROBIOTA AGAINST COLITIS CAUSED BY ADULT MICROBIOTA
24. Inulin-gel-based oral immunotherapy remodels the small intestinal microbiome and suppresses food allergy
25. IL-10 produced by macrophages regulates epithelial integrity in the small intestine
26. Regional Control of Regulatory Immune Cells in the Intestine
27. IL-15 promotes inflammatory Th17 cells in the intestine
28. Adherent-invasive E. coli – induced specific IgA limits pathobiont localization to the epithelial niche in the gut
29. The role of the microbiota in myelopoiesis during homeostasis and inflammation
30. Functional Characterization of Inflammatory Bowel Disease–Associated Gut Dysbiosis in Gnotobiotic Mice
31. The gut–liver axis in HCV infection
32. OXPHOS promotes apoptotic resistance and cellular persistence in T H 17 cells in the periphery and tumor microenvironment
33. Chapter Five - Immune response to intestinal microbial dysbiosis
34. Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction
35. IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections
36. Expression and regulation of proton-coupled oligopeptide transporters in colonic tissue and immune cells of mice
37. Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin
38. Regulation of virulence: the rise and fall of gastrointestinal pathogens
39. Maternal gut microbiome–induced IgG regulates neonatal gut microbiome and immunity
40. Untangling the oral–gut axis in the pathogenesis of intestinal inflammation
41. Tu1553: SPECIFIC IMMUNOGLOBLIN A INDUCED BY THE PERSISTENT COLONIZATION OF ADHERENT-INVASIVE E.COLI LIMITS PATHOBINT LOCALIZATION TO THE EPITHELIAL NICHE
42. Establishment of Novel Prediction System of Intestinal Absorption in Humans Using Human Intestinal Tissues
43. 1261 REGULATION OF INTRAEPITHELIAL CD8+ T CELL INTERACTION WITH EPITHELIAL MHC-I BY ABSENT IN MELANOMA 2 IN GASTRIC PRENEOPLASTIC LESIONS.
44. Tu1777 QUIESCENT CROHN'S DISEASE PATIENTS WITH PERSISTENT SYMPTOMS SHOW ENRICHMENT OF SULFUR METABOLITES AND SULFUR METABOLIC PATHWAYS
45. CD115− monocytic myeloid-derived suppressor cells are precursors of OLFM4high polymorphonuclear myeloid-derived suppressor cells.
46. Regulated Virulence Controls the Ability of a Pathogen to Compete with the Gut Microbiota
47. TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen
48. Periodontal connection with intestinal inflammation: Microbiological and immunological mechanisms
49. Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease
50. Site-specific adaptation mechanisms of an oral pathobiont in the oral and gut mucosae
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.